½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1508788

ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : Àü°³ ¹æ½Äº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Pharmaceutical Manufacturing Software Market, By Deployment Type, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 31¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024-2031³â CAGR 8.8%·Î 2031³â¿¡´Â 56¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×¸² 1. ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Pharmaceutical Manufacturing Software Market-IMG1

ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î´Â Á¦¾à »ê¾÷¿¡¼­ ÀǾàÇ° ¼³°è, ÀÓ»ó½ÃÇè, Ç°Áú º¸Áõ, Á¦Á¶ µî Á¦Á¶ °øÁ¤À» °£¼ÒÈ­ÇÏ´Â ÀÏ·ÃÀÇ ¼Ö·ç¼ÇÀ» ¸»ÇÕ´Ï´Ù. ±ÔÁ¦ ´ëÀÀ°ú È¿À²¼º¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁü¿¡ µû¶ó Á¦¾à»çµéÀº ÷´Ü Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î¸¦ µµÀÔÇÏ¿© ¾÷¹«ÀÇ °¡½Ã¼º°ú °ü¸®¼ºÀ» ³ôÀÌ°í ÀÖ½À´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾î´Â µðÁöÅÐ ±â·Ï °ü¸®, cGMP °¡À̵å¶óÀÎ Áؼö, Àç°í °ü¸®, ¹èÄ¡ »ý»ê ½ºÄÉÁÙ¸µ, °³¹ßÆÀ°ú »ý»êÆÀ °£ÀÇ Çù¾÷ ÃËÁø µîÀÇ ¾÷¹«¿¡ »ç¿ëµË´Ï´Ù. »ê¾÷¿ë »ç¹°ÀÎÅͳÝ(IIoT)ÀÇ ¼ºÀå°ú Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀÇ °¡¿ë¼ºÀº ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼ºÀåÀº Á¦¾à ¾÷°èÀÇ °ø±Þ¸Á °ü¸® ¹× Àç°í °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀåÇÏ°í ÀÖ½À´Ï´Ù. ÀǾàÇ° Á¦Á¶´Â º¹ÀâÇÑ ´Ù´Ü°è °øÁ¤°ú ±ÔÁ¦ Áؼö¸¦ Æ÷ÇÔÇϱ⠶§¹®¿¡ ¿øÀÚÀç, °øÁ¤ ¹× ¿ÏÁ¦Ç°ÀÇ Àç°í¸¦ È¿À²ÀûÀ¸·Î °ü¸®ÇØ¾ß ÇÕ´Ï´Ù. Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î´Â Á¦Ç° ¹èÄ¡ ÃßÀû, ¿øÀÚÀç »ç¿ë·® ÃßÀû, »ý»ê °èȹ ¹× ½ºÄÉÁÙ¸µ ÃÖÀûÈ­, ¿öÅ©Ç÷οì ÀÚµ¿È­¸¦ Áö¿øÇÏ¿© ¿î¿µ ºñ¿ëÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¦Ç° Ç°Áú ¹× ¹®¼­È­¿¡ ´ëÇÑ ¾ö°ÝÇÑ cGMP ¹× FDA ±ÔÁ¦´Â °ø±Þ¾÷ü¿¡°Ô ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ¾à±¹ Àü¿ë ¼ÒÇÁÆ®¿þ¾îÀÇ ³ôÀº µµÀÔ ¹× À¯Áöº¸¼ö ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ º¸¾È ¹× ÅëÇÕ ¹®Á¦µµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¾ÀÌ ¾ø´Â ±ÔÁ¦ ½ÅûÀ¸·ÎÀÇ Àüȯ°ú Àδõ½ºÆ®¸® 4.0 ±â¼úÀÇ Ã¤ÅÃÀº °¡±î¿î ¹Ì·¡¿¡ ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Ư¡

  • ÀÌ º¸°í¼­´Â 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ÅëÇØ ¼¼°è ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®Çß½À´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆà ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆà Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ¼¼°è ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÌÇØ °ü°èÀÚ°¡ ½±°Ô ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±Ý Á¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • Porters ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ À̴ϼÅƼºê
  • COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, Àü°³ ¹æ½Äº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • Ŭ¶ó¿ìµå
  • ¿ÂÇÁ·¹¹Ì½º

Á¦6Àå ¼¼°èÀÇ ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, ¿ëµµº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • ´ë±â¾÷
  • Áß¼Ò±â¾÷

Á¦7Àå ¼¼°èÀÇ ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • ¹ÙÀÌ¿ÀÀǾàÇ° ±â¾÷
  • ÀÇ·á±â±â ±â¾÷
  • °è¾à¿¬±¸±â°ü
  • Çмú¿¬±¸±â°ü
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÀǾàÇ° Á¦Á¶ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå, Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼Ò°³
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿

Á¦9Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • Oracle Corporation
    • Pegasystems Inc.
    • MasterControl Inc.
    • Veeva Systems Inc.
    • Siemens AG
    • Honeywell International Inc.
    • Werum IT Solutions GmbH
    • Dassault Systemes
    • Emerson Electric Co.
    • Rockwell Automation Inc.
    • Parsec Automation Corp.
    • ABB Ltd.
    • Aspen Technology Inc.
    • Schneider Electric SE
    • Korber AG
    • Sparta Systems Inc.
    • QAD Inc.
    • Kinaxis Inc.

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×

  • Wheel of Fortune
  • Coherent Opportunity Map

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
ksm 24.07.12

Global pharmaceutical manufacturing software market is estimated to be valued at USD 3.10 Bn in 2024 and is expected to reach USD 5.61 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

Figure 1. Pharmaceutical Manufacturing Software Market Share (%), By Region, 2024
Pharmaceutical Manufacturing Software Market - IMG1

Pharmaceutical manufacturing software refers to a suite of solutions that streamline production processes across drug design, clinical trials, quality assurance, and production in the pharmaceutical industry. With increasing regulatory compliances and demand for higher efficiency, pharmaceutical companies are adopting advanced manufacturing software to gain better visibility and control over their operations. This software is used in tasks like maintaining digital records, ensuring compliance with cGMP guidelines, managing inventory, scheduling batch production, and facilitating collaboration between development and production teams. Growing industrial internet of things (IIoT) and availability of cloud-based solutions can boost demand for pharmaceutical manufacturing software.

Market Dynamics:

Global pharmaceutical manufacturing software market growth is driven by growing need for supply chain management and inventory control in the industry. Pharmaceutical production involves complex multistep processes and regulatory compliance, requiring efficient management of raw materials, work-in-progress, and finished goods inventory. Manufacturing software helps to trace product batches, track material utilization, optimize production planning and scheduling, and automate workflows to minimize operational costs. Stringent cGMP and FDA regulations regarding product quality and documentation can offer opportunity to vendors. However, high implementation and maintenance costs of specialized pharmacy software can hamper the market growth. Data security and integration challenges can also hamper the market growth. The shift towards paperless regulatory filing and adoption of Industry 4.0 technologies can offer opportunities in the near future.

Key Features of the Study:

  • This report provides in-depth analysis of the global pharmaceutical manufacturing software market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharmaceutical manufacturing software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Oracle Corporation, Pegasystems Inc., MasterControl Inc., Veeva Systems Inc., Siemens AG, Honeywell International Inc., Werum IT Solutions GmbH, Dassault Systemes, Emerson Electric Co., Rockwell Automation Inc., Parsec Automation Corp., ABB Ltd., Aspen Technology Inc., Schneider Electric SE, Korber AG, Sparta Systems Inc., QAD Inc., Kinaxis Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global pharmaceutical manufacturing software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmaceutical manufacturing software market

Detailed Segmentation-

  • By Deployment Type
    • On-cloud
    • On-premise
  • By Application
    • Large Enterprises
    • Small and Midsize Enterprises
  • By End User
    • Biopharmaceutical Companies
    • Medical Device Companies
    • Contract Research Organizations
    • Academic Research Institutions
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Oracle Corporation
    • Pegasystems Inc.
    • MasterControl Inc.
    • Veeva Systems Inc.
    • Siemens AG
    • Honeywell International Inc.
    • Werum IT Solutions GmbH
    • Dassault Systemes
    • Emerson Electric Co.
    • Rockwell Automation Inc.
    • Parsec Automation Corp.
    • ABB Ltd.
    • Aspen Technology Inc.
    • Schneider Electric SE
    • Korber AG
    • Sparta Systems Inc.
    • QAD Inc.
    • Kinaxis Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Deployment Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Pharmaceutical Manufacturing Software Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Pharmaceutical Manufacturing Software Market, By Deployment Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • On-cloud
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • On-premise
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Pharmaceutical Manufacturing Software Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Large Enterprises
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Small and Midsize Enterprises
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Pharmaceutical Manufacturing Software Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Biopharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Device Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic Research Institutions
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Pharmaceutical Manufacturing Software Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Deployment Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Oracle Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pegasystems Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • MasterControl Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Veeva Systems Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Siemens AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Honeywell International Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Werum IT Solutions GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dassault Systemes
    • Emerson Electric Co.
    • Rockwell Automation Inc.
    • Parsec Automation Corp.
    • ABB Ltd.
    • Aspen Technology Inc.
    • Schneider Electric SE
    • Korber AG
    • Sparta Systems Inc.
    • QAD Inc.
    • Kinaxis Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦